(Q39002281)

8 September 2017

Reactive oxygen species generation is essential for cisplatin-induced accelerated senescence in hepatocellular carcinoma (English)

1 reference

8 September 2017

reactive oxygen species

1 reference

Kai Qu

1

1 reference

8 September 2017

Ting Lin

2

1 reference

8 September 2017

Zhixin Wang

3

1 reference

8 September 2017

Sinan Liu

4

1 reference

8 September 2017

Hulin Chang

5

1 reference

8 September 2017

Xinsen Xu

6

1 reference

8 September 2017

Fandi Meng

7

1 reference

8 September 2017

Lei Zhou

8

1 reference

8 September 2017

Jichao Wei

9

1 reference

8 September 2017

Minghui Tai

10

1 reference

8 September 2017

Yafeng Dong

11

1 reference

8 September 2017

Chang Liu

12

1 reference

8 September 2017

22 April 2014

1 reference

8 September 2017

Frontiers of medicine

1 reference

8 September 2017

8

1 reference

8 September 2017

2

1 reference

8 September 2017

227-235

1 reference

https://scigraph.springernature.com/pub.10.1007/s11684-014-0327-1

8 September 2017

0 references

cites work

THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS

1 reference

https://api.crossref.org/works/10.1007%2FS11684-014-0327-1

A biomarker that identifies senescent human cells in culture and in aging skin in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-014-0327-1

Cisplatin-induced senescence and growth inhibition in human non-small cell lung cancer cells with ectopic transfer of p16INK4a.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-014-0327-1

Reactive oxygen species generated in different compartments induce cell death, survival, or senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-014-0327-1

FoxM1c counteracts oxidative stress-induced senescence and stimulates Bmi-1 expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-014-0327-1

Escape from therapy-induced accelerated cellular senescence in p53-null lung cancer cells and in human lung cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-014-0327-1

Reactive oxygen species as mediators of cellular senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-014-0327-1

Cellular senescence, an unpopular yet trustworthy tumor suppressor mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-014-0327-1

Tumour biology: senescence in premalignant tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-014-0327-1

Senescence in tumours: evidence from mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-014-0327-1

Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-014-0327-1

p53-Dependent accelerated senescence induced by ionizing radiation in breast tumour cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-014-0327-1

Premature senescence is a major response to DNA cross-linking agents in BRCA1-defective cells: implication for tailored treatments of BRCA1 mutation carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-014-0327-1

Reprogramming of replicative senescence in hepatocellular carcinoma-derived cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-014-0327-1

Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-014-0327-1

Cellular senescence and tumor suppressor gene p16

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-014-0327-1

Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-014-0327-1

p53, ROS and senescence in the control of aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-014-0327-1

A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents

21 January 2018

1 reference

12 December 2020

Evidence of cisplatin-induced senescent-like growth arrest in nasopharyngeal carcinoma cells

1 reference

12 December 2020

DNA damage is able to induce senescence in tumor cells in vitro and in vivo.

1 reference

12 December 2020

Role of p53 and p21waf1/cip1 in senescence-like terminal proliferation arrest induced in human tumor cells by chemotherapeutic drugs

1 reference

12 December 2020

Negative regulation of transcription factor FoxM1 by p53 enhances oxaliplatin-induced senescence in hepatocellular carcinoma

1 reference

12 December 2020

Association of high-dose cyclophosphamide, cisplatin, and carmustine pharmacokinetics with survival, toxicity, and dosing weight in patients with primary breast cancer.

1 reference

12 December 2020

A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy

1 reference

12 December 2020

Ursodeoxycholic acid switches oxaliplatin-induced necrosis to apoptosis by inhibiting reactive oxygen species production and activating p53-caspase 8 pathway in HepG2 hepatocellular carcinoma

1 reference

12 December 2020

10.1007/S11684-014-0327-1

Identifiers

DOI

1 reference

8 September 2017

1 reference